MyeloAID
MyeloAID automates the morphological differentiation of bone marrow smears, turning a manual, time-consuming process into a swift guided review. It produces a detailed, reproducible bone marrow differential in seconds and works with the hardware you already own.
Our edge
MyeloAID is designed by hematologists and MTAs, for hematologists and MTAs. We make sure the software fits how labs actually work instead of forcing a new routine.
Our models learn from curated, proprietary datasets of healthy and diseased bone marrow from leading German hematology centres, labelled by over ten morphology experts.
How it works
MyeloAID never runs on its own. It does the heavy counting, and a human expert always reviews and approves the result. It is also hardware-agnostic: upload images from the microscope camera or scanner you already have to the Cancilico cloud platform, and MyeloAID returns a structured bone marrow differential and a PDF report you can link back to your LIS. Pick the workflow that matches how your hematology service works today.
HybridKeep working at the eyepiece. Your operator pans the slide and captures fields of view, and MyeloAID analyses the morphology as you go. It is a familiar way to work, with low up-front cost and a quick start. A good fit for low to medium volumes. No camera yet? We can advise and set you up with one for the best experience.
Fully digitalScan slides in batches and let MyeloAID run across the whole slide. It automatically selects regions of interest for you to accept or override. The results are reproducible, it scales to large teams, and it supports remote review. A good fit for high-volume hospitals and reference labs.
Either way, you get the same structured bone marrow differential and PDF report. We validate MyeloAID against common scanners and image formats, so for supported hardware new cases can land in the platform automatically. Tell us your scanner model and case volume, and we’ll tell you what to expect.
MyeloAID does not replace you. It takes the bulk of the repetitive counting off your hands, so you can focus on the difficult cases that need a trained eye. You stay in the driver’s seat: review what the AI proposes, and change the analysed regions or cell classes whenever your expert judgement says otherwise.
Manual differentials are slow, and two readers, or the same reader on two different days, can score the same slide differently. MyeloAID applies the same criteria every time, so it reduces inter- and intra-reader variability and gives you reproducible cyto-morphological analysis. You still own the diagnosis; the AI accelerates the counting so you can spend your time on interpretation and treatment decisions.
Because MyeloAID works with the imaging hardware you already own, you can add AI-assisted morphology without buying a six-figure scanner. It helps you control costs and take on more cases as demand grows, while keeping your reporting consistent across the lab.
MyeloAID is currently available for research use only (RUO); not for use in diagnostic procedures. We are working toward IVDR and FDA clearance.
Frequently asked questions
No. MyeloAID assists with cell counting and classification. A trained professional reviews the proposed regions and cell classes, makes corrections where needed, and remains responsible for the result.
No. MyeloAID is hardware-agnostic and works with almost any microscope camera or whole-slide scanner that can export a standard image file. In most cases, your lab can keep its existing imaging setup — there is no proprietary six-figure analyser to buy. Send us your hardware model and file format, and we’ll confirm compatibility.
With a microscope camera, the operator captures fields of view while working at the microscope. With a whole-slide scanner, slides can be digitised in batches, enabling automated region selection and remote review. Both workflows produce the same structured differential and PDF report.
MyeloAID produces a structured bone marrow cell differential and a PDF report.
By default, image data is processed in the Cancilico cloud platform, hosted in Hetzner data centres in Germany. MyeloAID is also available as a hybrid or on-premises deployment for laboratories that require analysis to stay inside their own network. The setup and data flow are agreed with each laboratory before onboarding.
MyeloAID is currently available for research use only and is not for use in diagnostic procedures. Cancilico is working toward IVDR and FDA clearance.
We start with a 45-minute online demo session using our digitised bone marrow samples and answer clinical, technical, and regulatory questions. Next, you can provide a selection of your own pseudonymised sample images. In a second session, we review MyeloAID’s results with you to give an initial indication of how the model performs on your samples. If MyeloAID looks like a fit, we can set up a one-month pilot on our cloud platform so your team can evaluate how it fits into your lab workflow.
Tell us your scanner model and case volume, and we’ll show you what MyeloAID can do on your own slides.
